Efficacy and safety of a new intravenous immunoglobulin (Panzyga(®)) in chronic immune thrombocytopenia

OBJECTIVES: To assess the efficacy and safety of intravenous immunoglobulin (IVIG) 10% (Panzyga(®)), a novel human normal IVIG 10%, in patients with chronic immune thrombocytopenia (ITP). BACKGROUND: First‐line treatment options in ITP include IVIGs. METHODS: In this prospective, open‐label, non‐con...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transfus Med
Asıl Yazarlar: Arbach, O., Taumberger, A. B., Wietek, S., Cervinek, L., Salama, A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Publishing Ltd 2019
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850321/
https://ncbi.nlm.nih.gov/pubmed/30687970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tme.12573
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller